TP53 and neoplasm: Conversely, in ID8-p53−/−Brca2−/− tumours, we found increased cDC1s (Fig. S7B) and fewer cDC2s (Fig. S7C) in Fgl2−/− mice, with no significant differences in co-stimulatory marker expression (Fig. S7D, E).